<?xml version="1.0" encoding="UTF-8"?>
<ref id="B109">
 <label>109.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Parra</surname>
    <given-names>LE</given-names>
   </name>
   <name>
    <surname>Borja-Cabrera</surname>
    <given-names>GP</given-names>
   </name>
   <name>
    <surname>Santos</surname>
    <given-names>FN</given-names>
   </name>
   <name>
    <surname>Souza</surname>
    <given-names>LOP</given-names>
   </name>
   <name>
    <surname>Palatnik-de-Sousa</surname>
    <given-names>CB</given-names>
   </name>
   <name>
    <surname>Menz</surname>
    <given-names>I</given-names>
   </name>
  </person-group>. 
  <article-title>Safety trial using the Leishmune vaccine against canine visceral leishmaniasis in Brazil</article-title>. 
  <source>Vaccine.</source> (
  <year>2007</year>) 
  <volume>25</volume>:
  <fpage>2180</fpage>â€“
  <lpage>6</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2006.11.057</pub-id>
  <?supplied-pmid 17239495?>
  <pub-id pub-id-type="pmid">17239495</pub-id>
 </mixed-citation>
</ref>
